Who is affected by this change?

This affects Independence Blue Cross Ophthalmology providers on Commercial plans.

When does this change take effect?

This change is effective Dec 10, 2025.

Back to dashboard

CommercialCoverageLow impact

07.13.11k, Contact Lenses for the Treatment of Persistent (Corneal) Epithelial Defects

Independence Blue Cross·Ophthalmology·Medical Policy

Effective date

Dec 10, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

This is a reissued medical policy for contact lenses used to treat persistent corneal epithelial defects, effective December 10, 2025. The policy appears to be a reissuance with no substantive changes indicated in the summary.

Action Required

Action needed

By December 10, 2025: Review the full policy at the provided URL to identify any changes to coverage criteria or billing requirements for contact lenses used to treat persistent corneal epithelial defects. Update billing procedures if needed based on the complete policy content.

Related policy hubs

Independence Blue Cross policies Ophthalmology